Literature DB >> 10598873

Immunohistochemical analysis of Fas ligand expression in normal human tissues.

S H Lee1, M S Shin, W S Park, S Y Kim, S M Dong, H K Lee, J Y Park, R R Oh, J J Jang, J Y Lee, N J Yoo.   

Abstract

Cross-linking of Fas and Fas ligand (FasL) induces apoptosis in Fas-bearing cells and regulates apoptosis. Fas is widely expressed in normal human tissues, but FasL expression has been considered to be restricted to lymphoid tissues. Recent studies have demonstrated that FasL is also expressed in some nonlymphoid tissues. To screen the in situ expression of FasL in normal human tissues, immunohistochemistry was performed using paraffin-embedded human tissues. FasL immunostaining was easily detected in testis, neurons, trophoblasts, tonsil, lymph node, Paneth cells, hepatocytes, renal tubular epithelium and bronchial epithelium, consistent with previous reports. Surprisingly, FasL was also expressed in many other cell types, including thymic medulla, skeletal muscle, cardiac muscle, pituitary gland, parathyroid gland, prostate glands, oocytes, epithelium of fallopian tube, endometrial glands, and gastric parietal cells. These findings demonstrate that FasL is widely expressed in human tissues and suggest that wide but cell-type specific expression of FasL may not only be implicated in the regulation of immune homeostasis but also in the regulation of cell death and life in many cell types in vivo.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10598873     DOI: 10.1111/j.1699-0463.1999.tb01504.x

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  7 in total

1.  Gonadal steroids modulate Fas-induced apoptosis of lactotropes and somatotropes.

Authors:  Gabriela Jaita; Sandra Zárate; Luciana Ferrari; Daniela Radl; Jimena Ferraris; Guadalupe Eijo; Verónica Zaldivar; Daniel Pisera; Adriana Seilicovich
Journal:  Endocrine       Date:  2010-11-11       Impact factor: 3.633

2.  Estrogens up-regulate the Fas/FasL apoptotic pathway in lactotropes.

Authors:  G Jaita; M Candolfi; V Zaldivar; S Zárate; L Ferrari; D Pisera; M G Castro; A Seilicovich
Journal:  Endocrinology       Date:  2005-08-11       Impact factor: 4.736

3.  Inverse relation of Fas-ligand and tumor-infiltrating lymphocytes in angiosarcoma: indications of apoptotic tumor counterattack.

Authors:  C Zietz; U Rumpler; M Stürzl; U Löhrs
Journal:  Am J Pathol       Date:  2001-09       Impact factor: 4.307

4.  The distribution and intracellular location of Fas and Fas Ligand following gastric carcinogenesis: Fas Ligand expressing gastric carcinoma cells can inhibit local immune response.

Authors:  Huanran Liu; Hideyuki Ubukata; Takanobu Tabuchi; Takeshi Nakachi; Hiroyuki Nagata; Jiro Shimazaki; Gyou Motohashi; Satoru Konishi; Motoi Nishimura; Tetsuro Satani; JianWei Hong; Ichiro Nakada; Abbi R Saniabadi; Takafumi Tabuchi
Journal:  Mol Cell Biochem       Date:  2009-05-21       Impact factor: 3.396

5.  Abundant Fas expression by gastrointestinal stromal tumours may serve as a therapeutic target for MegaFasL.

Authors:  B Rikhof; W T A van der Graaf; C Meijer; P T K Le; G J Meersma; S de Jong; J A Fletcher; A J H Suurmeijer
Journal:  Br J Cancer       Date:  2008-10-21       Impact factor: 7.640

Review 6.  Immunosuppressive Mechanisms of Malignant Gliomas: Parallels at Non-CNS Sites.

Authors:  Powell Perng; Michael Lim
Journal:  Front Oncol       Date:  2015-07-06       Impact factor: 6.244

7.  Cytotoxicity and pro-apoptosis activity of synthetic 1,3-thiazole incorporated phthalimide derivatives on cancer cells.

Authors:  Omid Tavallaei; Milad Heidarian; Marzieh Marzbany; Alireza Aliabadi
Journal:  Iran J Basic Med Sci       Date:  2021-05       Impact factor: 2.699

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.